Inflammatory breast issue

Journal of the National Cancer Institute

Volumn 95, Issue 16, 2003, Pages 1182-1184

  Coleman, C Norman ^a   Wallner, Paul E ^a   Abrams, Jeffrey S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; EDITORIAL; FOLLOW UP; HUMAN; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE; RADIATION FIELD; STANDARDIZATION; ADJUVANT THERAPY; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DECISION MAKING; EDUCATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE ORGANIZATION; INTRAOPERATIVE PERIOD; MEDICAL EDUCATION; METHODOLOGY; MORTALITY; NOTE; PATHOLOGY; RADIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE; UNITED STATES;

BRACHYTHERAPY; BREAST NEOPLASMS; DECISION MAKING; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MASTECTOMY, SEGMENTAL; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; RADIOLOGY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0042913369     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg027     Document Type: Editorial

References (24)

1. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003;95:1205-11.
2. Baglan KL, Martinez AA, Frazier RC, Kini VR, Kestin LL, Chen PY, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2001;50:1003-11.
3. Baglan KL, Sharpe MB, Jaffray D, Frazier RC, Fayad J, Kestin LL, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003;55:302-11.
4. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol 2001;19:1993-2001.
5. Vicini F, Baglan K, Kestin L, Chen P, Edmundson G, Martinez A. The emerging role of brachytherapy in the management of patients with breast cancer. Semin Radiat Oncol 2002;12:31-9.
6. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
7. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
8. Hahn CA, Marks LB, Chen DY, Lind PA, Lind HM, Prosnitz LR. Breast conservation rates-barriers between tertiary care and community practice. Int J Radiat Oncol Biol Phys 2003;55:1196-9.
9. Hokanson P, Seshadri R, Miller KD. Underutilization of breast-conserving therapy in a predominantly rural population: need for improved surgeon and public education. Clin Breast Cancer 2000;1:72-6.
10. Young WW, Marks SM, Kohler SA, Hsu AY. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy. Med Care 1996;34:1003-17.
11. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000;180:299-304.
12. Kuske RR Jr. Breast brachytherapy. Hematol Oncol Clin North Am 1999; 13:543-58, vi-vii.
13. Lawenda BD, Taghian AG, Kachnic LA, Hamdi H, Smith BL, Gadd MA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003;56:671-80.
14. Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002;53:889-97.
15. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002;80:121-8; discussion 129.
16. Edmundson GK, Vicini FA, Chen PY, Mitchell C, Martinez AA. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2002;52:1132-9.
17. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003;55:289-93.
18. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001;37: 2178-83.
19. Veronesi U, Gatti G, Luini A, Intra M, Orecchia R, Borgen P, et al. Intraoperative radiation therapy for breast cancer: technical notes. Breast J 2003;9:106-12.
20. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002; 94:1143-50.
21. Nag S, Kuske RR, Vicini FA, Arthur DW, Zwicker RD. Brachytherapy in the treatment of breast cancer. Oncology (Huntingt) 2001;15:195-202, 205; discussion 205-7.
22. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993-2000.
23. Fisher B, Dignam J, Bryant J, Wolmark N. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl Cancer Inst 2001;93:684-90.
24. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001;28:400-18.